HealthStream Inc
Change company Symbol lookup
Select an option...
HSTM HealthStream Inc
LJPC La Jolla Pharmaceutical Co
NBR Nabors Industries Ltd
GPRO GoPro Inc
DDD 3D Systems Corp
AAPL Apple Inc
ARNC Arconic Inc
AA Alcoa Corp
MU Micron Technology Inc
NFLX Netflix Inc
Go

Health Care : Health Care Technology | Small Cap GrowthCompany profile

HealthStream, Inc. (HealthStream) provides workforce and provider solutions for healthcare organizations. It operates in two segments: HealthStream Workforce Solutions and HealthStream Provider Solutions. Its products and services are organized into two segments: Workforce Solutions and Provider Solutions. Its products and services help healthcare organizations meet ongoing talent management, training, education, assessment, competency management, compliance, provider credentialing and privileging management, and provider enrollment needs. Its solutions are provided to a range of customers within the healthcare industry across the continuum of care. Delivered primarily as Software-as-a-Service, its solutions focus on challenges facing the healthcare workforce and healthcare organizations, including the need to manage, retain, engage and develop healthcare workforce talent; manage ongoing medical staff credentialing and deliver patient experiences of care in healthcare organizations.

Postmarket

Last Trade
Delayed
$27.41
0.10 (0.37%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$27.31
Day's Change
0.23 (0.85%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
27.53
Day's Low
26.89
Volume
(Heavy Day)
Volume:
113,061

10-day average volume:
92,230
113,061

ADTRAN SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In ADTRAN, Inc. To Contact The Firm

1:44 pm ET October 22, 2019 (Newsfile) Print

New York, New York--(Newsfile Corp. - October 22, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in ADTRAN, Inc. (NASDAQ: ADTN) ("ADTRAN" or the "Company")  of the December 16, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6455/49010_8a2f35cd04f9288b_logo_lg.jpg



Faruqi & Faruqi Logo

If you invested in ADTRAN stock or options between February 28, 2019 and October 9, 2019 and would like to discuss your legal rights, click here:www.faruqilaw.com/ADTN. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll freeat 877-247-4292 or at 212-983-9330 or by sending an e-mail torgonnello@faruqilaw.com.

CONTACT:

FARUQI & FARUQI, LLP

685 Third Avenue, 26th Floor

New York, NY 10017

Attn: Richard Gonnello, Esq.

rgonnello@faruqilaw.com

Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased ADTRAN securities between February 28, 2019 and October 9, 2019 (the "Class Period"). The case, Burbridge v. ADTRAN, Inc. et al., No. 19-cv-09619 was filed on October 17, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that there were material weaknesses in the Company's internal control over financial reporting; (2) that, as a result, certain E&O reserves had been improperly reported; (3) that, as a result, the Company's financial results for certain periods were misstated; (4) that there would be a pause in shipments to the Company's Latin American customer; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

On July 17, 2019 the Company announced "preliminary" earnings for second quarter 2019 due to its ongoing assessment of the reasonableness of its current and previously reported excess and obsolete inventory reserves.

On this news, the Company's stock price fell from $15.82 per share on July 17, 2019 to $12.13 per share on July 18, 2019: a $3.69 or 23.32% drop.

Then, on October 9, 2019, after-market, the Company announced that its "revenue this quarter has been significantly impacted by a pause in shipments to a Tier 1 customer in Latin America and the continued slowdown in the spending at an international Tier 1 customer."

On this news, the Company's stock price fell from $10.91 per share on October 9, 2019 to $8.81 per share on October 10, 2019: a $2.10 or 19.25% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding ADTRAN's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/49010

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.